Strong CAGR to Propel in the Antimicrobial Resistance Surveillance Market and Beyond upto $10.05 Billion by 2029
Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What is the Projected CAGR for the Antimicrobial Resistance Surveillance Market Size from 2025 to 2034?
There has been significant growth in the size of the antimicrobial resistance surveillance market in the recent past. It is projected to expand from $6.77 billion in 2024 to $7.3 billion in 2025, boasting a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this impressive growth in the historic period include the heightened usage of antibiotics in agricultural practices, excessive prescribing of antibiotics in the healthcare sector, insufficient diagnostic testing, substandard practices in preventing and controlling infection, and the surge in global trade and travel.
The market size for antimicrobial resistance surveillance is projected to experience considerable expansion in the upcoming years. It is predicted to reach a value of $10.05 billion in 2029, growing at a compound annual growth rate (CAGR) of 8.3%. The predicted growth during the forecast period can be credited to escalated awareness regarding antimicrobial resistance, strides in diagnostic technologies, increased governmental contributions and initiatives, a surge in healthcare correlated infections, and the establishment of new antibiotics and alternative solutions. Prominent trends anticipated within the forecast period encapsulate the utilization of artificial intelligence for data examination, progressive sequencing technologies, the advent of real-time surveillance systems, molecular diagnostic instruments coupled with the amalgamation of substantial data and machine learning for predictive framework.
Download a free sample to assess the report’s scope and structure:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21100&type=smp
Which Primay Drivers Are Accelerating Growth in the Antimicrobial Resistance Surveillance Market?
Growth in the antimicrobial resistance surveillance market is projected to surge in relation to the escalating occurrence of infectious diseases. These diseases, triggered by harmful microbes like bacteria, viruses, fungi, or parasites, can be directly or indirectly transferred from person to person. Factors boosting the prevalence of infectious diseases include climate change, urbanization, and global travel. These elements intensify the dissemination of pathogens and increase human susceptibility to unfamiliar microbes. Antimicrobial resistance surveillance serves a primary role in monitoring resistant pathogen distribution, enabling effective treatment plans and shaping public health policy to fight these diseases. For example, a report in February 2024 by the UK Health Security Agency, a government agency in the UK, noted a rise in tuberculosis (TB) cases in England by 10.7% in 2023, reporting 4,850 cases, a growth from 4,380 in 2022. Consequently, with the ongoing growth in infectious diseases, the antimicrobial resistance surveillance market continues to expand.
Which Primary Segments of the Antimicrobial Resistance Surveillance Market Are Driving Growth and Industry Transformations?
The antimicrobial resistance surveillancemarket covered in this report is segmented –
1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services
2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications
3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users
Subsegments:
1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits
2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems
3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems
4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services
Request customized data on this market:
https://www.thebusinessresearchcompany.com/customise?id=21100&type=smp
Which Regions Are Key Players in the Growth of the #Which Primay Drivers Are Accelerating Growth in the Antimicrobial Resistance Surveillance Market?# Market?
North America was the largest region in the antimicrobial resistance surveillance market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the antimicrobial resistance surveillance market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Which Technological Trends Are Reshaping the Antimicrobial Resistance Surveillance Industry Dynamics?
Key market players are prioritizing the development of advanced technologies, such as new diagnostic tools, in an effort to optimize procedures, boost efficacy, heighten precision, lower expenses, and offer improved results for patients and end-users. Diagnostic tools may include any equipment, device, software, or techniques utilized to diagnose, identify, or evaluate a particular condition, illness, or problem. For example, in June 2023, Sysmex Astrego AB, a Swedish company specializing in diagnostic product services, announced the release of the PA-100 AST Point-of Care Testing System. This system permits quick and precise detection of antimicrobial resistance at the point of care, delivering a significant reduction in time versus conventional lab methods that could take up to several days. With the capability to provide results in as little as 30 minutes, it enables medical professionals to swiftly and knowledgeably make decisions regarding optimal treatment for infections, reducing dependence on wide-ranging antibiotics and aiding in the fight against the rise of antimicrobial resistance.
View the full report here:
What Parameters Are Used to Define the Antimicrobial Resistance Surveillance Market?
Antimicrobial resistance (AMR) surveillance refers to the systematic monitoring and tracking of the prevalence and spread of antimicrobial-resistant microorganisms. They are used for detecting emerging resistance patterns, guiding public health interventions, and informing treatment strategies to combat infections caused by resistant bacteria, viruses, and fungi.
Purchase the full report and get a swift delivery:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21100
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
